|
4GDK
Crystal Structure of Human Atg12~Atg5 Conjugate in Complex with an N-terminal Fragment of Atg16L1
Deposited 2012-07-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
11–43(33 aa)
Chain F
11–43(33 aa)
|
Not recorded
|
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;PROTEIN: 10 MG/ML in 0.01M HEPES pH 7.0, 0.3 M NaCl, 0.001 M DTT; RESERVOIR: 0.1M Hepes pH7.5, 0.2 M lithium citrate, 20% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.70 Å
R-free 0.236
|
|
4GDL
Crystal Structure of Human Atg12~Atg5 Conjugate in Complex with an N-terminal Fragment of Atg16L1
Deposited 2012-07-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
11–43(33 aa)
|
Not recorded
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;PROTEIN: 10 MG/ML in 0.01M HEPES pH 7.0, 0.3 M NaCl, 0.001 M DTT; RESERVOIR: 0.1M BICINE pH9.0, 0.2 M sodium phosphate dibasic, 18% PEG 3350, vapor diffusion, hanging drop, temperature 293K, VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.88 Å
R-free 0.254
|
|
4NAW
Crystal Structure of Human ATG12~ATG5-ATG16N in complex with a fragment of ATG3
Deposited 2013-10-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
11–43(33 aa)
Fragment:UNP residues 11-43
|
Not recorded
|
SO4 SULFATE ION × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;PROTEIN - 10 MG/ML in 0.01M HEPES pH 7.0, 0.15 M NaCl, 0.001 M DTT, RESERVOIR - 0.1M MES pH6.0-6.75, 0.2 M ammonium sulfate, 10-16% PEG 5000 MME, vapor diffusion, sitting drop, temperature 293K
|
Resolution 2.19 Å
R-free 0.215
|
|
4NAW
Crystal Structure of Human ATG12~ATG5-ATG16N in complex with a fragment of ATG3
Deposited 2013-10-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain G
11–43(33 aa)
Fragment:UNP residues 11-43
|
Not recorded
|
SO4 SULFATE ION × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;PROTEIN - 10 MG/ML in 0.01M HEPES pH 7.0, 0.15 M NaCl, 0.001 M DTT, RESERVOIR - 0.1M MES pH6.0-6.75, 0.2 M ammonium sulfate, 10-16% PEG 5000 MME, vapor diffusion, sitting drop, temperature 293K
|
Resolution 2.19 Å
R-free 0.215
|
|
4NAW
Crystal Structure of Human ATG12~ATG5-ATG16N in complex with a fragment of ATG3
Deposited 2013-10-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain K
11–43(33 aa)
Fragment:UNP residues 11-43
|
Not recorded
|
SO4 SULFATE ION × 4
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;PROTEIN - 10 MG/ML in 0.01M HEPES pH 7.0, 0.15 M NaCl, 0.001 M DTT, RESERVOIR - 0.1M MES pH6.0-6.75, 0.2 M ammonium sulfate, 10-16% PEG 5000 MME, vapor diffusion, sitting drop, temperature 293K
|
Resolution 2.19 Å
R-free 0.215
|
|
4NAW
Crystal Structure of Human ATG12~ATG5-ATG16N in complex with a fragment of ATG3
Deposited 2013-10-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain O
11–43(33 aa)
Fragment:UNP residues 11-43
|
Not recorded
|
SO4 SULFATE ION × 3
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;PROTEIN - 10 MG/ML in 0.01M HEPES pH 7.0, 0.15 M NaCl, 0.001 M DTT, RESERVOIR - 0.1M MES pH6.0-6.75, 0.2 M ammonium sulfate, 10-16% PEG 5000 MME, vapor diffusion, sitting drop, temperature 293K
|
Resolution 2.19 Å
R-free 0.215
|
|
5D7G
Structure of human ATG5 E122D-ATG16L1 complex at 3.0 Angstroms
Deposited 2015-08-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–69(69 aa)
Fragment:UNP residues 1-69
Chain D
1–69(69 aa)
Fragment:UNP residues 1-69
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;Micro crystal: 37.5 mM MES, pH 5.2 to pH 5.8, 0.2 M sodium tartrate, and 11 to 13% polyethylene glycol 3350; Micor seeding condition:40 mM MES, pH 5.5, 0.2M sodium tartrate, 8.5% PEG3350, 10 mM DTT
|
Resolution 3.00 Å
R-free 0.244
|
|
5D7G
Structure of human ATG5 E122D-ATG16L1 complex at 3.0 Angstroms
Deposited 2015-08-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain F
1–69(69 aa)
Fragment:UNP residues 1-69
Chain H
1–69(69 aa)
Fragment:UNP residues 1-69
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;Micro crystal: 37.5 mM MES, pH 5.2 to pH 5.8, 0.2 M sodium tartrate, and 11 to 13% polyethylene glycol 3350; Micor seeding condition:40 mM MES, pH 5.5, 0.2M sodium tartrate, 8.5% PEG3350, 10 mM DTT
|
Resolution 3.00 Å
R-free 0.244
|
|
5NPV
Structure of human ATG5-ATG16L1(ATG5BD) complex (I4)
Deposited 2017-04-19
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
11–307(297 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.76;293 K;0.1 M MES pH 5.76, 0.378 M KCl, 21.7 % PEG 3350
|
Resolution 3.10 Å
R-free 0.278
|
|
5NPV
Structure of human ATG5-ATG16L1(ATG5BD) complex (I4)
Deposited 2017-04-19
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
11–307(297 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.76;293 K;0.1 M MES pH 5.76, 0.378 M KCl, 21.7 % PEG 3350
|
Resolution 3.10 Å
R-free 0.278
|
|
5NPW
Structure of human ATG5-ATG16L1(ATG5BD) complex (C2)
Deposited 2017-04-19
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
11–307(297 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.4 M KCl and 18 % PEG 3350
|
Resolution 3.10 Å
R-free 0.264
|
|
5NPW
Structure of human ATG5-ATG16L1(ATG5BD) complex (C2)
Deposited 2017-04-19
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
11–307(297 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.4 M KCl and 18 % PEG 3350
|
Resolution 3.10 Å
R-free 0.264
|
|
5NPW
Structure of human ATG5-ATG16L1(ATG5BD) complex (C2)
Deposited 2017-04-19
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
11–307(297 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.4 M KCl and 18 % PEG 3350
|
Resolution 3.10 Å
R-free 0.264
|
|
5NPW
Structure of human ATG5-ATG16L1(ATG5BD) complex (C2)
Deposited 2017-04-19
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
11–307(297 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.4 M KCl and 18 % PEG 3350
|
Resolution 3.10 Å
R-free 0.264
|
|
5NUV
Structure of the WD40-domain of human ATG16L1
Deposited 2017-05-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–607(305 aa)
|
Mutation:E354A/K355A/Y607P
|
BU3 (R,R)-2,3-BUTANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.3;303 K;1.61 M (NH4)2SO4, 0.09 M NaCl, 0.1 M MES pH 6.3
|
Resolution 1.55 Å
R-free 0.197
|
|
7W36
Crystal structure of human Atg5 complexed with a stapled peptide
Deposited 2021-11-25
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
13–33(21 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;20% PEG 3350, 0.2M MgCl2, 0.1M Tris-HCl pH8.5
|
Resolution 3.00 Å
R-free 0.287
|
|
7XFR
Crystal structure of WIPI2b in complex with the second site of ATG16L1
Deposited 2022-04-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
124–188(65 aa)
Chain D
124–188(65 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;289 K;0.1 M MES monohydrate(pH 6.5), 12% w/v Polyethylene glycol 20000
|
Resolution 1.76 Å
R-free 0.193
|
|
8ZQG
Crystal structure of WIPI3 in complex with ATG16L1
Deposited 2024-06-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
124–188(65 aa)
Chain D
124–188(65 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.8;289 K;0.02 M Citric acid, 0.08 M BIS-TRIS propane (pH 8.8); 16% w/v Polyethylene glycol 3350
|
Resolution 2.77 Å
R-free 0.233
|
|
9H2Q
Stabilized complex of Chlamydia trachomatic efector CT622 in complex with human WD40 domain of ATG16L1
Deposited 2024-10-14
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
303–607(305 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE
|
Resolution 3.80 Å
|
|
9J54
Crystal structure of FIP200 Claw in complex with ATG16L1
Deposited 2024-08-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
235–247(13 aa)
Chain D
235–247(13 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;289 K;10% v/v 2-Propanol, 0.1 M BICINE (pH 8.5), 30% w/v Polyethylene glycol 1500
|
Resolution 1.61 Å
R-free 0.216
|
|
9JF2
Crystal structure of GABARAPL1 in complex with ATG16L1
Deposited 2024-09-03
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
235–247(13 aa)
|
Not recorded
|
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;289 K;0.1 M Sodium cacodylate (pH 6.5), 40% v/v MPD, 5% w/v PEG 8000
|
Resolution 1.76 Å
R-free 0.215
|
|
9JF2
Crystal structure of GABARAPL1 in complex with ATG16L1
Deposited 2024-09-03
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
235–247(13 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;289 K;0.1 M Sodium cacodylate (pH 6.5), 40% v/v MPD, 5% w/v PEG 8000
|
Resolution 1.76 Å
R-free 0.215
|